Literature DB >> 34128207

Rat-Induced Pluripotent Stem Cells-Derived Cardiac Myocytes in a Cell Culture Dish.

Fatima Bianca A Dessouki1, Pawan K Singal2, Dinender K Singla3.   

Abstract

Induced pluripotent stem (iPS) cells are genetically reprogrammed somatic cells that exhibit embryonic stem cell-like characteristics such as self-renewal and pluripotency. These cells have broad differentiation capability to convert into diverse cell types that make up the primary germ layers during embryonic development. iPS cells can spontaneously differentiate and form cell aggregates termed embryoid bodies (EBs) in the absence of differentiation inhibitory factors. Unlike other methods used to generate EBs, "the hanging drop" method offers reproducibility and homogeneity from a set number of iPS cells. As such, we describe the differentiation of rat-induced pluripotent stem cells into cardiac myocytes in vitro using the hanging drop method. Both the confirmation and identification of the cardiac myocytes are done using immunocytochemistry, RT-PCR, Western Blot, and Flow Cytometry. Briefly, a specific number of iPS cells are placed in droplets on the lid of culture dishes and incubated for 2 days, yielding embryoid bodies, which are suspended and plated. Spontaneous beating of cardiomyocytes can be seen 7-14 days after the plating of EBs and specific cardiac markers can be observed through identification assays.
© 2021. Springer Science+Business Media, LLC.

Entities:  

Keywords:  Cardiac myocytes; Cell culture and differentiation; Embryoid bodies; Hanging drop method; Induced-pluripotent stem cells

Mesh:

Year:  2022        PMID: 34128207     DOI: 10.1007/7651_2021_406

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

Review 1.  Why stem cells?

Authors:  D van der Kooy; S Weiss
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Generation of pluripotent stem cells from adult mouse liver and stomach cells.

Authors:  Takashi Aoi; Kojiro Yae; Masato Nakagawa; Tomoko Ichisaka; Keisuke Okita; Kazutoshi Takahashi; Tsutomu Chiba; Shinya Yamanaka
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

Review 3.  Embryonic and adult stem cell therapy.

Authors:  Anne C Brignier; Alan M Gewirtz
Journal:  J Allergy Clin Immunol       Date:  2010-01-12       Impact factor: 10.793

4.  Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins?

Authors:  Kazim H Narsinh; Jordan Plews; Joseph C Wu
Journal:  Mol Ther       Date:  2011-04       Impact factor: 11.454

Review 5.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

Review 6.  Recent progress in induced pluripotent stem cell-derived cardiac cell sheets for tissue engineering.

Authors:  Botao Gao; Katsuhisa Matsuura; Tatsuya Shimizu
Journal:  Biosci Trends       Date:  2019       Impact factor: 2.400

7.  Embryonic stem cells and iPS cells: sources and characteristics.

Authors:  Catherine H Hackett; Lisa A Fortier
Journal:  Vet Clin North Am Equine Pract       Date:  2011-06-16       Impact factor: 1.792

8.  Induced pluripotent reprogramming from promiscuous human stemness related factors.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Amber A Mael; Andre Terzic; Yasuhiro Ikeda
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

9.  Notch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failure.

Authors:  Hilda Merino; Dinender K Singla
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 10.  Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair.

Authors:  Chengming Fan; Eric Zhang; Jyotsna Joshi; Jinfu Yang; Jianyi Zhang; Wuqiang Zhu
Journal:  Front Cell Dev Biol       Date:  2020-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.